BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 22465179)

  • 1. Honokiol induces cell cycle arrest and apoptosis via inhibition of survival signals in adult T-cell leukemia.
    Ishikawa C; Arbiser JL; Mori N
    Biochim Biophys Acta; 2012 Jul; 1820(7):879-87. PubMed ID: 22465179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Butein inhibits NF-κB, AP-1 and Akt activation in adult T-cell leukemia/lymphoma.
    Ishikawa C; Senba M; Mori N
    Int J Oncol; 2017 Aug; 51(2):633-643. PubMed ID: 28586006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-adult T-cell leukemia effects of Bidens pilosa.
    Nakama S; Ishikawa C; Nakachi S; Mori N
    Int J Oncol; 2011 Apr; 38(4):1163-73. PubMed ID: 21318218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-regulation of c-Src/EGFR-mediated signaling activation is involved in the honokiol-induced cell cycle arrest and apoptosis in MDA-MB-231 human breast cancer cells.
    Park EJ; Min HY; Chung HJ; Hong JY; Kang YJ; Hung TM; Youn UJ; Kim YS; Bae K; Kang SS; Lee SK
    Cancer Lett; 2009 May; 277(2):133-40. PubMed ID: 19135778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Curcumin (diferuloylmethane) inhibits constitutive active NF-kappaB, leading to suppression of cell growth of human T-cell leukemia virus type I-infected T-cell lines and primary adult T-cell leukemia cells.
    Tomita M; Kawakami H; Uchihara JN; Okudaira T; Masuda M; Takasu N; Matsuda T; Ohta T; Tanaka Y; Ohshiro K; Mori N
    Int J Cancer; 2006 Feb; 118(3):765-72. PubMed ID: 16106398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peridinin, a carotenoid, inhibits proliferation and survival of HTLV-1-infected T-cell lines.
    Ishikawa C; Jomori T; Tanaka J; Senba M; Mori N
    Int J Oncol; 2016 Oct; 49(4):1713-21. PubMed ID: 27499015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of hippuristanol, an inhibitor of eIF4A, on adult T-cell leukemia.
    Tsumuraya T; Ishikawa C; Machijima Y; Nakachi S; Senba M; Tanaka J; Mori N
    Biochem Pharmacol; 2011 Mar; 81(6):713-22. PubMed ID: 21219881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclinical effects of honokiol on treating glioblastoma multiforme via G1 phase arrest and cell apoptosis.
    Lin CJ; Chang YA; Lin YL; Liu SH; Chang CK; Chen RM
    Phytomedicine; 2016 May; 23(5):517-27. PubMed ID: 27064011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Honokiol inhibits TNF-alpha-stimulated NF-kappaB activation and NF-kappaB-regulated gene expression through suppression of IKK activation.
    Tse AK; Wan CK; Shen XL; Yang M; Fong WF
    Biochem Pharmacol; 2005 Nov; 70(10):1443-57. PubMed ID: 16181613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Honokiol, a chemopreventive agent against skin cancer, induces cell cycle arrest and apoptosis in human epidermoid A431 cells.
    Chilampalli C; Guillermo R; Kaushik RS; Young A; Chandrasekher G; Fahmy H; Dwivedi C
    Exp Biol Med (Maywood); 2011 Nov; 236(11):1351-9. PubMed ID: 21908486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of CUDC-907, a dual phosphoinositide-3 kinase and histone deacetylase inhibitor, in inhibiting proliferation of adult T-cell leukemia.
    Ishikawa C; Mori N
    Eur J Haematol; 2020 Dec; 105(6):763-772. PubMed ID: 32780889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Honokiol, a potential therapeutic agent, induces cell cycle arrest and program cell death in vitro and in vivo in human thyroid cancer cells.
    Lu CH; Chen SH; Chang YS; Liu YW; Wu JY; Lim YP; Yu HI; Lee YR
    Pharmacol Res; 2017 Jan; 115():288-298. PubMed ID: 27940017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and significance of Pim-3 kinase in adult T-cell leukemia.
    Ishikawa C; Senba M; Hashimoto T; Imaizumi A; Mori N
    Eur J Haematol; 2017 Dec; 99(6):495-504. PubMed ID: 28833639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A modified version of galectin-9 suppresses cell growth and induces apoptosis of human T-cell leukemia virus type I-infected T-cell lines.
    Okudaira T; Hirashima M; Ishikawa C; Makishi S; Tomita M; Matsuda T; Kawakami H; Taira N; Ohshiro K; Masuda M; Takasu N; Mori N
    Int J Cancer; 2007 May; 120(10):2251-61. PubMed ID: 17278100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-adult T-cell leukemia effects of brown algae fucoxanthin and its deacetylated product, fucoxanthinol.
    Ishikawa C; Tafuku S; Kadekaru T; Sawada S; Tomita M; Okudaira T; Nakazato T; Toda T; Uchihara JN; Taira N; Ohshiro K; Yasumoto T; Ohta T; Mori N
    Int J Cancer; 2008 Dec; 123(11):2702-12. PubMed ID: 18798263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of PKC-δ in HTLV-1-infected T cells.
    Mori N; Ishikawa C; Senba M
    Int J Oncol; 2015 Apr; 46(4):1609-18. PubMed ID: 25625567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Honokiol inhibits in vitro and in vivo growth of oral squamous cell carcinoma through induction of apoptosis, cell cycle arrest and autophagy.
    Huang KJ; Kuo CH; Chen SH; Lin CY; Lee YR
    J Cell Mol Med; 2018 Mar; 22(3):1894-1908. PubMed ID: 29363886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histone deacetylase inhibitors induce growth arrest and apoptosis of HTLV-1-infected T-cells via blockade of signaling by nuclear factor kappaB.
    Nishioka C; Ikezoe T; Yang J; Komatsu N; Bandobashi K; Taniguchi A; Kuwayama Y; Togitani K; Koeffler HP; Taguchi H
    Leuk Res; 2008 Feb; 32(2):287-96. PubMed ID: 17644177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Honokiol inhibits signal transducer and activator of transcription-3 signaling, proliferation, and survival of hepatocellular carcinoma cells via the protein tyrosine phosphatase SHP-1.
    Rajendran P; Li F; Shanmugam MK; Vali S; Abbasi T; Kapoor S; Ahn KS; Kumar AP; Sethi G
    J Cell Physiol; 2012 May; 227(5):2184-95. PubMed ID: 21792937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Honokiol potentiates apoptosis, suppresses osteoclastogenesis, and inhibits invasion through modulation of nuclear factor-kappaB activation pathway.
    Ahn KS; Sethi G; Shishodia S; Sung B; Arbiser JL; Aggarwal BB
    Mol Cancer Res; 2006 Sep; 4(9):621-33. PubMed ID: 16966432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.